The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

  new date UPDATE  ESFH 21st  Congress    2021,  May 26th - 27th 
    Presentations  and Session Videos

H. Vrielink Convalescent Plasma: from whom and when (pdf) 
Video
Hans Vrielink  MD PhD: Convalescent plasma: from whom and when

M.Lozano  Apheresis techniques in the treatment of severe COVID-19 patients (pdf)
Video: Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients

L.Pierelli  Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic(pdf)
Video  Luca Pierell: Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic

M.-J Mustieles:Vascular Aaccess: Always Central Line?  (pdf)
Video Maria-Jesus Mustieles: Vascular Aaccess: Always Central Line?

  Video Marie Scully: New treatment strategies in management of TTP   

 

 
                   PROGRAM
Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...
In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...
In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...